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Substantial  evidence  has  been  accumulated  for  a  major  role  of T  cells  or  their 
factors  in  B  cell  proliferation  and  maturation.  Recent  reports  have  suggested  that 
certain T  cells may be responsible for specific isotype expression on B  cells (1-3). This 
has been most clearly demonstrated for IgE (1), but recent evidence has also implicated 
such cells in IgG and IgA systems  (2, 3). There  is also evidence that  these factors may 
act by inducing an Ig class switch  (2, 4). 
Immortalization  of functional  T  cells  through  T  cell  hybridomas  has  proved  of 
considerable use in the mouse system, and  some results have also been obtained with 
human  T  cell hybridomas  (5-7).  This methodology was used  in our laboratory  in an 
attempt  to obtain  different T  cell factors  involved in  B  cell activation  and  compare 
their effect on isolated normal  B  cells and  monoclonal B  cell leukemias. 
Materials and Methods 
Cell Separation and Culture Conditions.  Leukocyte concentrate packs  obtained  from  the New 
York Blood Center,  New York,  were used  as  a  source of peripheral  blood mononuclear cells 
(PBMC).  Tonsillar tissue  was  obtained  from  routine  tonsillectomy specimens.  Mononuclear 
cells and T/B separations were prepared as previously described (8).  Non-T cells were rosetted 
twice before use, resulting in <1% OKT 3 + (pan T  cell marker; Ortho Pharmaceutical, Raritan, 
N  J) cells in this population. Isolated T  cells were cultured in complete medium (8) or subjected 
to a further rosetting procedure to enrich for OKT-4  + (helper/inducer T  cell marker) cells used 
for fusion. An indirect rosetting technique was used; 40 ×  106 T  cells were incubated in OKT- 
8  antibody  (suppressor/cytotoxic T  cell marker)  and  rosetted with goat  anti-mouse Ig-coated 
ox erythrocytes (RBC), coated by a  chromium chloride technique (8).  The resulting interface, 
after  Ficoll-Hypaque gradient  centrifugation,  was  90-95%  OKT-4 +  and  <1%  OKT-8 +  by 
indirect immunofluorescence. The OKT-4  + cells were incubated with concanavalin A  (Con A) 
(Sigma Chemical Co., St. Louis, MO),  10/~g/ml, for 72 h  at a cell concentration of 1-2 ×  106/ 
ml. These stimulated  cells were washed  three  times in  serum-free medium  before use in  cell 
fusion. 
Establishment of Hypoxanthine Guanine Phosphoribosyl Transferase (HGPR  T)-deficient Human T Cell 
Lines  for Fusion.  Jurkat, a human T  cell lymphoma line, and KE 37, a human T  cell ALL line, 
were mutagenized with ethylmethane sulfonate at  a  concentration of 200/~g/ml according to 
Epstein et al.  (9).  80% of treated cells died from this treatment,  but  after 2 wk in culture, the 
remaining 20% were _>95% viable. HGPRT-deficient mutants  were selected in 6-thioguanine 
and cloned on soft agar with human 6-thioguanine-resistant fibroblasts (Gm 1362; The Human 
Genetic Mutant  Cell Repository, Camden,  N J).  Resultant clones were tested for aminopterin 
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sensitivity with dose ranges of 10-7-10  -9 M. Clones were selected on the basis of their cloning 
efficiency and the presence of a clear-cut level of aminopterin sensitivity. 
Fusion Procedure.  Fusion of peripheral blood  (PB)  -activated T  cells was performed with 
mutagenized Jurkat 3 or KE 37.3.2 clones, or a  nonmutagenized Jurkat 2 T  cell line. In the 
former case, 2 ×  107 Con A-stimulated PB T cells or OKT-4  + T cells were pelleted with 1 ×  107 
KE 37.3.2 or Jurkat 3, respectively. Pellets were resuspended in polyethylene glycol (PEG) 1000 
(Merck Chemical Div., Merck & Co., Inc., Rahway, NJ) and centrifuged for 8 min at room 
temperature at 150 g. The cells were washed free of PEG with serum-free medium and cultured 
in 96-well, flat-bottomed microwell plates (Linbro Chemical Co., Hamden, CT) at a concen- 
tration of 1 ×  105 mutant cells/well. Hybrid culture medium consisted of RPMI  1640,  20% 
fetal calf serum, penicillin/streptomycin, and  2  mM  glutamine. In addition, hypoxanthine, 
10  -4 M, and thymidine, 1.6 ×  10  -6 M, were added. After 24 h at 37°C, 5% CO2, and 95% room 
air, aminopterin, 3 ×  10  -s M, was added. After 14-17 d  in culture, with feeding every 3rd d, 
all nonfused control cultures were nonviable. Growth-positive wells were transferred out of 
aminopterin and  into 24-well, flat-bottomed macrowell plates (Linbro Chemical Co.). With 
continued growth, cultures were maintained in 25-cm  2 culture flasks (3013;  Falcon Labware, 
Oxnard, CA), and cell-free supernatants were obtained and tested for functional capabilities. 
Fusion of aetivated T  cells with a nonmutagenized T  cell line, Jurkat 2, was performed in a 
similar manner except that no hypoxanthine, aminopterin, thymidine (HAT) was added to the 
cultures. Donor cells in this case were known to HLA-B27  + as measured by staining with a 
monoclonal antibody (N. L. Cappel Laboratories, Cochranville, PA). Because all wells showed 
positive growth by this method, single wells were cloned on soft agar, 0.6% (SeaKem, Rockland, 
ME) using human fibroblasts as a feeder layer (Gm 1604).  Resultant clones were stained with 
the HLA B27 antibody, with the positive clones being selected for further study. 
HLA  Typing.  HLA typing of parental lines and fusion products was kindly performed by 
Dr. M. Fotino of the New York Blood Center. 
Immunofluorescence and Fc Receptors.  Direct and  indirect staining methods for surface and 
intracytoplasmic staining was performed as previously described (8).  Fc receptors were deter- 
mined by the ability of T  cells to  form  rosettes with  human  IgG, IgA, or IgM chromium 
chloride-coupled ox RBC. 
Plaque Assay.  Purified B or non-T cell populations were placed in culture medium with 10- 
30% hybrid supernatant at a concentration of 1 ×  106 cells/ml, in an effort to determine the 
supernatant's ability to induce B cell maturation. Cultures were maintained at 37°C, 5% CO2, 
and 95% room air. A reverse hemolytic plaque was performed to evaluate Ig isotype production 
on day 6 (10). 
B Cell Proliferation.  Resting B cells were incubated as above in  10-30% hybrid supernatant 
in triplicate 0.1-ml cultures at a cell concentration of 1 ×  106 cells/ml. On days 2-5, 2 #Ci of 
aqueous methyl [3H]thymidine (sp act 2.5  mCi; Schwartz/Mann Div., Becton, Dickinson & 
Co., Orangeberg, NY) were added, and after 12 h  the cells were harvested and processed for 
scintillation counting. Average counts per minute of the triplicate cultures divided by counts 
per minute of the media control was the stimulation index. 
Results 
Characterization of T-THybrids.  63 out of 180 wells showed positive growth after 4- 
6 wk in HAT medium (31/90 from the Jurkat 3 fusion and 32/90 from the KE 37 3.2 
fusion). Four of these hybrids showed potent activity of interest when tested function- 
ally, as described below, including one B27 + clone from the fusion with the nonmu- 
tagenized Jurkat line. The parental lines, Jurkat 2 and 3, were typed as HLA A2, A4, 
B7,  and  CW4.  The  normal  donor T  cells expressed HLA  A1,  A30,  B35,  BI7,  and 
CW4.  Fusion product J1  and  its clone JI.3,  expressed A1  and  BI7  from  the donor 
cells as well as A2 and B7 from the Jurkat line. Surface marker studies revealed that 
JI.3, as well as Jurkat 3, was OKT-3 +, T4 +, T8-,  la-, Fcy-, and Fca-. However, the 
hybrid was Fop  +, whereas the parental line was not.  Hybrids K1  and  K8 expressed 
HLA A1 and BI7 from the donor T  cells, and were OKT-4 +, whereas the KE37 3.2 
line was not. J2S 1 expressed HLA B27 from its donor parent. 1862  MAYER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Functional Characteristics of the Supernatants 
B  CELL DWVERENTIATION.  Supernatants  from  hybrid  cultures  were  added  to  a 
purified population  of tonsil  B  cells.  In  the  control cultures,  with  media alone,  no 
IgA-specific PFC were seen (Table I). Addition of supernatant from hybrid clone J 1.3 
resulted in 700 IgA-specific plaque-forming cells (PFC)/weI1. The addition of T  cells 
without  supernatant  yielded  only  100  IgA-specific PFC  and  a  different  isotypic 
pattern. Similar data were obtained using a  different tonsil B cell preparation, with 
an eightfold increase in IgA PFC over control. This effect could still be demonstrated 
with  the  supernatant  diluted  to  1:100  (Table  I).  PB  non-T  cells,  cultured  in  the 
presence of supernatant, also resulted in an increase in IgA-specific PFC, approaching 
that seen with autologous T  cells and pokeweed mitogen (PWM). 
The J1.3  supernatant  also caused differentiation of monoclonal leukemic B  lym- 
phocytes that  had  membrane IgA. These cells were  derived  from a  case of B  cell 
leukemia with  a  leukocyte count  of  100,000/ram a,  due  to  membrane  IgA-bearing 
lymphocytes. A few plasma cells with cytoplasmic IgA were also seen in the peripheral 
blood.  Table  II  shows  the  marked  increase  in  IgA  PFC  as  well  as  plasma  cells, 
determined by fluorescent analysis with anti-IgA antiserum, after the addition of  J 1.3 
supernatant. Similar differentiation was observed after addition of allogeneic T  cells 
and PWM, or addition ofJ2S1 supernatant  (see below). 
Hybrid J2S 1 had a different effect. Addition of this supernatant induced polyclonal 
B  cell  differentiation  with  large  increases  in  PFC  of all  isotypes  (Table  I).  These 
supernatants appeared to be especially potent, with activity present, although dimin- 
ished, at a dilution of 1:200  (Table I). Supernatants from the parental line Jurkat 3, 
as well as hybrids K1 and K8, which promote B cell proliferation (see below), failed 
to induce B cell differentiation (Table I). 
TABLE  I 
Induction of lg Secretion by Hybrid Supernatants 
B Cells 
Media control  Supernatant*  Plus autologous T  cells 
(;  A  MJ;  G  A  M  G  A  M 
T  cell hybridomaJI.3  Tonsil Bi  0  0  10()  200  700  0  0  100  800 
Tonsil B..,  0  300  0  0  2,400  0  -- 
Tonsil B:~  20  0  0  90  600  20  -- 
Tonsil B:~  20  0  (1  I 0  260  0§  -- 
PB non-T~  0  0  0  100  700  0  3A20¶  88011  1,22011 
PBMC  0  0  0  0  500  0  -- 
T  cell hybridoma J2S1  Tonsil B4  40  0  90  520  B0  450  190  30  20 
GAM¶  (;AM  (;AM 
T  cell hybridomaJ2Sl  Tonsil B5  50  1170  -- 
Tonsil B:,  50  170**  -- 
PB non-T~  100  700  l,(iO()][ 
Hybrids KI  Tonsil B6  0  0  -- 
K8  Tonsil B~  0  0 
Parent  line Jurkat 3  Tonsil B,~  0  0 
* Supernatant  at  1:3 dilution. 
J~ PFC/10 ~ cells at initiation of culture.  Ig isotypes measured by reverse plaque assay at day 6. 
§ Supernatant  at  1  : 100 dilution. 
][ Plus T  +  PWM. 
¶  Reverse plaque assay recognizing all isotypes. 
** Supernatant  at  1:200 dilution. MAYER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Differentiation of Monoclonal IgA-bearing Leukemic Lymphocytes in the Presence of Hybrid 
Supernatants 
1863 
Added cells or supernatant 
PFC/well*  Fluorescence:~ 
G  A  M  G  A  M 
Media control  0  600  0  0  7  0 
JI.3  200  18,000  0  0  80§  l 
J2Sl  0  16,000  600  0  70§  ;2 
AIlogeneic  T  cells  200  1,800  0  0  7  2 
Allogeneic  T  cells and PWM  400  22,800  600  1  50  2 
PWM (l: 100)  ND I]  ND  ND  I  7  2 
* PFC/well on day 6 of cuhure, as per Table I. 
:~ Intracytoplasmic staining in  fixed preparations on  day  6  after  addition of supernatant  at  a  l(YT~ 
concentration. 
§ Very bright fluorescence. 
II  Not done. 
~  12 
0.  2 
X 
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J 
d 
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Fro.  1.  Stimulation index (experiment cpm/control cpm) of resting B cells at days 2-5, incubated 
in hybrid supernatants K1  (U]), K8  (11), J1.3  (O), j2s1  (0), or parental line KE37.3.2  (A). 
B  CELL PROLIFERATION.  [aH]thymidine uptake of purified tonsil B cells incubated 
with or without supernatant were measured at days 2-5  (Fig.  1).  Supernatants from 
hybrids K1 and K8 induced B cell proliferation on day 3, with stimulation indices of 
20.6 and 31.4, respectively. As noted above, this proliferation was not associated with 
B  cell  maturation.  Hybrids J1.3  and J2S1  induced  only  modest  increases  in  [3H]- 
thymidine uptake, and the parental line KE 37 3.2 did not stimulate at all (Fig.  1). 
Discussion 
In the present study we  have generated a  series of human T  cell  hybridomas by 
fusion of normal activated T  cells with T  cell lines, either rendered HGPRT deficient 1864  MAYER ET AL.  BRIEF  DEFINITIVE REPORT 
by treatment  with  ethylmethane sulfonate or  used  intact.  HLA typing and  other 
surface characteristics revealed that the hybrids expressed HLA A, B, or C  determi- 
nants  or  surface  markers  of both  parental  cells.  Two  different  methods  used  for 
selecting T-T hybrids proved satisfactory in the production of functional hybrids. Our 
experience with  the hybrids showed that  they were  not  stable  in  continous culture 
and  repeated  subcloning was  necessary to  maintain  function.  In  this  manner,  the 
hybrids were maintained for 6-8 mo. 
One particular hybrid, J 1, and its clone, J 1.3 were shown to constitutively produce 
a factor that enhanced IgA secretion by normal human tonsil or PB B cells, as well as 
by  monoclonal  leukemic  B  cells  with  membrane  IgA.  It  had  little  effect  on  the 
production of IgG and  IgM and  was therefore clearly class specific. The effect on 
monoclonal leukemic B cells with  membrane IgA was of special  interest.  Virtually 
complete differentiation  was  observed.  This  provided strong evidence  for a  direct 
effect of the J1.3 factor on B cells.  The cells  of this patient were also inducible with 
allogeneic T  cells and PWM as well as the polyclonal activator J2S 1. Also of interest 
is the fact that the J1.3 hybrid had Fc receptors for/1 and not c~, in contrast to the IgA 
helper T  cells described by others (4,  11). 
T  cell influence on Ig isotype expression has been described for several classes of Ig. 
Helper T  cells  for IgG and IgE (1) as well as IgG subclasses have been demonstrated 
(12). Isotype switching is influenced by T  cells (13),  and as shown more recently (2), 
factors from murine T  cell lines appear to induce a  switch from IgG- to IgG  + cells. 
IgA class-specific T  cell help has been described in murine Peyer's patches (3) and in 
the peripheral  blood of humans using isolated Fca  + T  cells  (11).  Clones of Peyer's 
patch T  cells have been shown to cause a switch from surface IgM  +o to surface IgA  +- 
bearing B  cells,  without  increase  in  IgA production  (4). This  suggests that  several 
factors may be necessary for the final secretion of IgA. 
Exactly where our hybrid J1.3 acts in the stages of B cell differentiation is unclear 
at present. Data have been obtained showing that depletion of surface IgA-bearing B 
cells  eliminates  the effect of the supernatant  (L.  Mayer, unpublished  observation). 
This suggests that the factor acts on a post-switch, IgA-committed B cell. 
The other hybrids described above differ from J 1.3  in several important respects. 
J2S 1 induces polyclonai differentiation with increases in IgG and IgM as well as IgA, 
in striking contrast to J1.3. This hybrid may be similar to that described by Irigoyen 
et al. (5), except that prestimulation of the B cells with PWM was not necessary with 
J2S1.  In  addition,  two  other  hybrids  were  studied  that  did  not  induce  B  cell 
differentiation, but  rather caused active proliferation of resting B cells.  The factors 
from these clones may be analogous to B cell growth factors described in Con A- and 
phytohemagglutinin-stimulated T  cell supernatants (14,  15). 
Current efforts are being directed toward defining the molecular nature of these 
factors  and  their  specific  B  cell  target.  The  monoclonal  leukemic  B  cells  were 
stimulated to differentiate by both the IgA-specific and polyclonal factors. It would 
be of interest  to  determine whether the  same receptor site  is  involved. The  use  of 
monoclonal B cell targets appears to be of special value in these studies. 
Summary 
Human T-T hybridomas were established  by fusion of concanavalin A-activated 
OKT-4  + T  cells with hypoxanthine guanine phosphoribosyl transferase-deficient as 
well  as  nondeficient  T  celt  lines.  Four  hybrids  were  selected  for  further  study. MAYER  ET AL.  BRIEF DEFINITIVE REPORT  1865 
Supernatant  from  hybrid  clone  J1.3  specifically  enhanced  IgA  production  and 
secretion  by  isolated  human  B  cells,  with  increases  in  IgA  plaque-forming  cells 
approaching those seen with addition of autologous T  cells and pokeweed mitogen. A 
monoclonal lymphocytic leukemia  with  membrane  IgA also  differentiated  to  IgA 
plasma cells by this supernatant.  Evidence suggests that this hybrid supernatant  acts 
on post-switch IgA-committed B  cells.  The other hybrids were not  isotype specific; 
hybrid J2S 1 enhanced polyclonal Ig secretion and hybrids K 1 and K8 induced B cell 
proliferation without induction of Ig secretion. 
We thank Nicholas Chiorazzi for providng the IgA-bearing leukemic cells, and Chris Thompson 
and Judy Damiani for their expert technical assistance. 
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